Brucella melitensis M5-90Δbp26 as a potential live vaccine that allows for the distinction between natural infection and immunization.

Brucella is Gram-negative intracellular bacterial pathogen that infects humans and animals and contributes to great economic losses in developing countries. Presently, live attenuated Brucella vaccines (Brucella melitensis M5-90) are the most effective means of brucellosis control and prevention in animals. However, these vaccines have several drawbacks, such as an inability to distinguish between a natural infection and immunization and an association with abortions in pregnant animals. Therefore, this study constructed a Brucella M5-90Δbp26 mutant and evaluated its virulence. The survival of the M5-90Δbp26 mutant was attenuated in human placenta trophoblastic 8 cells (HPT-8 cells) and in BALB/c mice, with a high immunoprotectivity noted in mice. Furthermore, safety tests showed that the M5-90Δbp26 mutant was less virulent than the M5-90 vaccine strain. Additionally, an indirect enzyme-linked immunosorbent assay (ELISA) screening was shown to detect the presence of Brucella protein 26 (BP26) with high sensitivity, with M5-90Δbp26 inoculation accompanied with a lack of BP26 expression, and was further confirmed by western blotting. Together, the M5-90Δbp26 mutant and the indirect ELISA can be employed to distinguish vaccinated livestock from infected animals.

[1]  A. Saharee,et al.  Immuno-pathophysiological responses of mouse model to experimental infection with Brucella melitensis and its lipopolysaccharides via intraperitoneal route. , 2016, Microbial pathogenesis.

[2]  K. Beckmen,et al.  Removal of Lipid from Serum Increases Coherence between Brucellosis Rapid Agglutination Test and Enzyme-linked Immunosorbent Assay in Bears in Alaska, USA , 2016, Journal of Wildlife Diseases.

[3]  Hai Jiang,et al.  Genotyping of Brucella melitensis and Brucella abortus strains currently circulating in Xinjiang, China. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[4]  Kun Xu,et al.  A novel recombinant multi-epitope protein against Brucella melitensis infection. , 2016, Immunology letters.

[5]  Tiansen Li,et al.  The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice , 2016, World journal of microbiology & biotechnology.

[6]  S. Crosson,et al.  Brucella abortus Cell Cycle and Infection Are Coordinated. , 2015, Trends in microbiology.

[7]  Z. Kianmehr,et al.  Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19 , 2015, Jundishapur journal of microbiology.

[8]  Tiansen Li,et al.  Brucella melitensis 16MΔTcfSR as a potential live vaccine allows for the differentiation between natural and vaccinated infection. , 2015, Experimental and therapeutic medicine.

[9]  Jing Zhang,et al.  A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy. , 2015, Molecular immunology.

[10]  Grant M. Rotskoff,et al.  Structural asymmetry in a conserved signaling system that regulates division, replication, and virulence of an intracellular pathogen , 2015, Proceedings of the National Academy of Sciences.

[11]  Lan Yao,et al.  Immunogenic response to a recombinant pseudorabies virus carrying bp26 gene of Brucella melitensis in mice. , 2015, Research in veterinary science.

[12]  R. Ranjbar,et al.  Immune reactivity of sera obtained from brucellosis patients and vaccinated-rabbits to a fusion protein from Brucella melitensis , 2015, Iranian journal of basic medical sciences.

[13]  R. Ranjbar,et al.  In silico analysis of chimeric TF, Omp31 and BP26 fragments of Brucella melitensis for development of a multi subunit vaccine candidate , 2014, Iranian journal of basic medical sciences.

[14]  M. Islam,et al.  A review of Brucella seroprevalence among humans and animals in Bangladesh with special emphasis on epidemiology, risk factors and control opportunities. , 2013, Veterinary microbiology.

[15]  Sidang Liu,et al.  Comparison of Genomes of Brucella melitensis M28 and the B. melitensis M5-90 Derivative Vaccine Strain Highlights the Translation Elongation Factor Tu Gene tuf2 as an Attenuation-Related Gene , 2013, Infection and Immunity.

[16]  Ji-Joon Song,et al.  Brucella immunogenic BP26 forms a channel-like structure. , 2013, Journal of molecular biology.

[17]  Chuangfu Chen,et al.  Characterization of Periplasmic Protein BP26 Epitopes of Brucella melitensis Reacting with Murine Monoclonal and Sheep Antibodies , 2012, PloS one.

[18]  Z. Bu,et al.  Complete Genome Sequences of Brucella melitensis Strains M28 and M5-90, with Different Virulence Backgrounds , 2011, Journal of bacteriology.

[19]  Hu Sen,et al.  Expression, purification, and improved antigenic specificity of a truncated recombinant bp26 protein of Brucella melitensis M5‐90: a potential antigen for differential serodiagnosis of brucellosis in sheep and goats , 2011 .

[20]  Ashu S. Kumar,et al.  Cloning and expression of the immunoreactive Brucella melitensis 28 kDa outer-membrane protein (Omp28) encoding gene and evaluation of the potential of Omp28 for clinical diagnosis of brucellosis. , 2010, Journal of medical microbiology.

[21]  K. Laroucau,et al.  Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams. , 2009, Vaccine.

[22]  R. Gilman,et al.  Human brucellosis. , 2007, The Lancet. Infectious diseases.

[23]  E. Moreno,et al.  Rough vaccines in animal brucellosis: structural and genetic basis and present status. , 2004, Veterinary research.

[24]  E. Olfert,et al.  Guide to the care and use of experimental animals , 1993 .